Frontier Capital Management’s Adaptimmune Therapeutics ADAP Stock Holding History

Frontier Capital Management’s Portfolio ADAP Stock Details ADAP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell
2018 Q3	$9.47M	Buy
2018 Q2	$1.84M	Buy